Recent publications


Reaction Biology Corporation (“RBC”) is a premier provider of in vitro enzyme activity assays for HTS and profiling. Serving over 300 customers worldwide, we specialize in optimizing nanoliter scale assaying methods, allowing for high quality data with fast turnaround and economical pricing. RBC offers gold-standard radioisotope based assays in the Kinase, Methyltransferase, and HAT enzyme classes, as well as full suite of HDAC/SIRT assays. RBC also now provides an expanding line of active, human recombinant HMTs, including some exclusive complexes. Compound libraries, custom assay development, discovery partnerships and cell-based assays are also part of our portfolio of services. Please contact us at 877-347-2368 or sales@reactionbiology.com for any inquiries.

Next Generation Kinase Inhibitors, June 17-19, Boston, MA
More >

8th Protein Kinases in Drug Discovery –GTC, Boston, MA, July 8-10, 2013
More >

EpiCongress, Boston, MA, July 23-26, 2013
More >


EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
More >

HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner
More >

Reaction Biology Top-Ranked in Kinase Profiling Survey
More >